Kwality Pharmaceuticals opened higher at ₹3,583.30, compared with its previous close of ₹3,565.50. During today's session, the stock has traded between ₹3,429.30 and ₹3,597.80, with an average traded price of ₹3,484.21. It is currently showing a downward intraday trend.
An investment of ₹10,000 made 1 year ago in Kwality Pharmaceuticals is now worth
₹ 21,252.00
giving a profit of
₹ 11,252.00 (112.52%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-32.20 (-0.90%)
Day High
₹3,597.80
Day Low
₹3,429.30
Day Open
₹3,583.30
Prev Close
₹3,565.50
Volume
25,874
Value Traded
₹9.02 Cr
1W Return
-3.04%
1M Return
-3.02%
3M Return
35.92%
6M Return
112.52%
1Y Return
112.52%
Market Cap (₹ Cr.)
3,666
PE Ratio
45.60
PB Ratio
11.17
Dividend Yield
-
ROE
20.41%
ROCE
27.40%
Book Value (₹)
318.80
Face Value (₹)
10.00
EPS (TTM)
24.69
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-3.04%
6 Week
-
1 Month
-3.02%
3 Month
35.92%
9 Month
112.52%
Kwality Pharmaceuticals holds virtual investor meet on August 10, 2026
Kwality Pharmaceuticals Limited conducted a virtual investor meet on August 10, 2026, discussing operations and outlook via public data only. The event complied with SEBI Regulation 30, with no unpublished price-sensitive information shared.
2mo agoKwality Pharma targets ₹1,500 crore revenue by FY30, appoints KPMG
Kwality Pharmaceuticals raised its long-term outlook, targeting ₹1,500 crore revenue by FY30 with 30% EBITDA margins. The company plans to spend ₹185-190 crore on capex for hormone and oncology expansions and will appoint KPMG as its auditor by Q3FY27.
2mo agoKwality Pharmaceuticals sets Aug 25-31 book closure for AGM
Kwality Pharmaceuticals Ltd has scheduled its 43rd AGM for August 31, 2026, with a book closure period from August 25 to 31. The company detailed the e-voting timeline, cut-off dates for notice and voting eligibility, and key agenda items including director reappointments and cost auditor remuneration.
2mo agoKwality Pharmaceuticals hosts Q1FY27 earnings call on Aug 10
Kwality Pharmaceuticals Limited announced its Q1FY27 earnings call scheduled for August 10, 2026, at 4:00 PM IST. Managing Director Ramesh Kumar and Director & CFO Aditya Arora will participate. Investors are required to pre-register to access the call hosted by Go India Advisors.
2mo agoKwality Pharmaceuticals Gets CDSCO Nod for Pembrolizumab Pilot Batches
Kwality Pharmaceuticals secured CDSCO approval on July 24, 2026, to manufacture Pembrolizumab pilot batches for preclinical studies, transitioning the biologics candidate from R&D to active preclinical evaluation. The Amritsar-based company aims to be among the first generic manufacturers to launch Pembrolizumab in India post-patent expiry, with clinical trials and commercial launch approvals still pending.
2mo agoKwality Pharmaceuticals appoints Swanith Kapoor as Independent Director
Kwality Pharmaceuticals Limited restructured its Board by appointing Mr. Swanith Kapoor as an Additional Independent Director for a five-year term effective June 02, 2026, subject to shareholder approval. Concurrently, Mr. Kartik Kapur resigned as Independent Director effective the close of business hours on June 02, 2026, citing other professional commitments. The company confirmed Mr. Kapoor's independence and that Mr. Kapur held no other directorships in listed entities.
4mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% |
An investment of ₹10,000 made 1 year ago in Kwality Pharmaceuticals is now worth
₹ 21,252.00
giving a profit of
₹ 11,252.00 (112.52%)
Note: Past profits do not guarantee future returns.
